Biologic-Based Asthma Treatment Gaining Momentum – Medscape


Medscape

Biologic-Based Asthma Treatment Gaining Momentum
Medscape
DENVER — The monoclonal antibody dupilumab (Sanofi, Regeneron) improves lung function and reduces severe exacerbations in patients with asthma, according to results presented here at the American Thoracic Society 2015 International Conference …
Regeneron speeds toward the FDA with its would-be asthma blockbusterFierceBiotech
Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in PR Newswire (press release)
Sanofi, Regeneron Announce Positive Phase 2 Data for Asthma DrugDrug Discovery & Development
Healio
all 13 news articles »

View full post on asthma – Google News

Boston Scientific to Buy Asthmatx for $193.5 Million Gaining Asthma Device – Bloomberg

View full post on asthma – Google News